drugset / Trial / NCT03131791

Comparing the Radial Extracorporeal Shock Waves and Botulinum Toxin Injection for Spasticity

NCT03131791

Completed 42 enrolled Mackay Memorial Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Botulinum toxin type A (BoNT-A) is widely used in the clinics to reduce spasticity and improve upper limb function for post-stroke patients. However, there were no studies to compare the effect of rESWT and BoNT-A injection for treatment on spasticity.

Timeline

Start
2017-04-01
Primary completion
2017-07-01
Completion
2017-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 500 iu